Mahsa Keshavarz‐Fathi

1.8k total citations
36 papers, 1.2k citations indexed

About

Mahsa Keshavarz‐Fathi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mahsa Keshavarz‐Fathi has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Mahsa Keshavarz‐Fathi's work include Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (6 papers) and Immune cells in cancer (6 papers). Mahsa Keshavarz‐Fathi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (6 papers) and Immune cells in cancer (6 papers). Mahsa Keshavarz‐Fathi collaborates with scholars based in Iran, United States and India. Mahsa Keshavarz‐Fathi's co-authors include Nima Rezaei, Sepideh Razi, Neda Khalili, Nastaran Khalili, Maryam Ebrahimi, Vickie E. Baracos, Mohammad Amin Sadeghi, Maryam Mahmoudi, Jann Arends and Antonella Argentiero and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cytokine & Growth Factor Reviews and Medicinal Research Reviews.

In The Last Decade

Mahsa Keshavarz‐Fathi

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahsa Keshavarz‐Fathi Iran 16 431 416 411 149 135 36 1.2k
Biao Zhang China 22 252 0.6× 321 0.8× 594 1.4× 225 1.5× 140 1.0× 65 1.5k
Yuchao Chen China 22 246 0.6× 384 0.9× 590 1.4× 117 0.8× 47 0.3× 74 1.5k
Ke Su China 23 201 0.5× 243 0.6× 579 1.4× 309 2.1× 74 0.5× 84 1.3k
Hang Yu China 19 209 0.5× 260 0.6× 610 1.5× 266 1.8× 72 0.5× 94 1.4k
Xi Huang United States 24 252 0.6× 297 0.7× 622 1.5× 354 2.4× 169 1.3× 77 2.1k
Kee‐Lung Chang Taiwan 28 203 0.5× 267 0.6× 770 1.9× 212 1.4× 112 0.8× 62 1.9k
Sepideh Razi Iran 14 337 0.8× 294 0.7× 323 0.8× 151 1.0× 31 0.2× 39 920
Guoying Zhu China 18 320 0.7× 136 0.3× 703 1.7× 186 1.2× 137 1.0× 55 1.4k
Haitian Lu United States 12 358 0.8× 327 0.8× 384 0.9× 252 1.7× 46 0.3× 15 1.3k
Shidong Wang China 23 274 0.6× 328 0.8× 667 1.6× 316 2.1× 62 0.5× 92 1.7k

Countries citing papers authored by Mahsa Keshavarz‐Fathi

Since Specialization
Citations

This map shows the geographic impact of Mahsa Keshavarz‐Fathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahsa Keshavarz‐Fathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahsa Keshavarz‐Fathi more than expected).

Fields of papers citing papers by Mahsa Keshavarz‐Fathi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahsa Keshavarz‐Fathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahsa Keshavarz‐Fathi. The network helps show where Mahsa Keshavarz‐Fathi may publish in the future.

Co-authorship network of co-authors of Mahsa Keshavarz‐Fathi

This figure shows the co-authorship network connecting the top 25 collaborators of Mahsa Keshavarz‐Fathi. A scholar is included among the top collaborators of Mahsa Keshavarz‐Fathi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahsa Keshavarz‐Fathi. Mahsa Keshavarz‐Fathi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Darbeheshti, Farzaneh, Sepideh Kadkhoda, Mahsa Keshavarz‐Fathi, et al.. (2022). Investigation of BRCAness associated miRNA-gene axes in breast cancer: cell-free miR-182-5p as a potential expression signature of BRCAness. BMC Cancer. 22(1). 668–668. 12 indexed citations
2.
Makuku, Rangarirai, Neda Khalili, Sepideh Razi, Mahsa Keshavarz‐Fathi, & Nima Rezaei. (2021). Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy. Journal of Immunology Research. 2021. 1–15. 90 indexed citations
3.
Keshavarz‐Fathi, Mahsa, et al.. (2021). Aberrant DNA methylation of the promoters of JAK2 and SOCS3 in juvenile systemic lupus erythematosus. European Cytokine Network. 32(3). 48–54. 5 indexed citations
4.
Razi, Sepideh, et al.. (2021). A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications. Translational Lung Cancer Research. 10(4). 1889–1916. 130 indexed citations
5.
Sheida, Fateme, Sepideh Razi, Mahsa Keshavarz‐Fathi, & Nima Rezaei. (2021). The role of myeloid-derived suppressor cells in lung cancer and targeted immunotherapies. Expert Review of Anticancer Therapy. 22(1). 65–81. 13 indexed citations
6.
Seyedmirzaei, Homa, Mahsa Keshavarz‐Fathi, Sepideh Razi, Masoumeh Gity, & Nima Rezaei. (2021). Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2). Journal of Oncology Pharmacy Practice. 27(5). 1235–1244. 5 indexed citations
7.
Pezeshki, Parmida Sadat, et al.. (2021). Advances in pharmacotherapy for neuroblastoma. Expert Opinion on Pharmacotherapy. 22(17). 2383–2404. 4 indexed citations
8.
Gouravani, Mahdi, Nastaran Khalili, Sepideh Razi, et al.. (2020). The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Review of Clinical Immunology. 16(2). 175–187. 28 indexed citations
9.
Aghamiri, Shahin, Sam Talaei, Elnaz Fazeli, et al.. (2020). Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy. Expert Opinion on Drug Delivery. 17(6). 753–766. 29 indexed citations
10.
Razi, Sepideh, et al.. (2020). Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site. Cancer Immunology Immunotherapy. 69(9). 1673–1697. 60 indexed citations
11.
Jabbari, Parnian, et al.. (2020). Importance of TNF-alpha and its alterations in the development of cancers. Cytokine. 130. 155066–155066. 64 indexed citations
12.
Ebrahimi, Maryam, Neda Khalili, Sepideh Razi, et al.. (2020). Effects of lead and cadmium on the immune system and cancer progression. Journal of Environmental Health Science and Engineering. 18(1). 335–343. 173 indexed citations
13.
Keshavarz‐Fathi, Mahsa, et al.. (2020). Extensive Deep Tissue Involvement in Nicolau Syndrome and Below-Knee Amputation: A Case Report and Literature Review. The International Journal of Lower Extremity Wounds. 22(1). 113–116. 4 indexed citations
14.
Rahmani, Farzaneh, Mahsa Keshavarz‐Fathi, Sara Hanaei, et al.. (2019). Universal Scientific Education and Research Network (USERN): Step Strong in Scientific Networking. SHILAP Revista de lepidopterología.
15.
Soleymanjahi, Saeed, et al.. (2019). The Promising Role of Monoclonal Antibodies for Gastric Cancer Treatment. Immunotherapy. 11(4). 347–364. 5 indexed citations
16.
Razi, Sepideh, et al.. (2019). IL-17 and colorectal cancer: From carcinogenesis to treatment. Cytokine. 116. 7–12. 97 indexed citations
17.
Eskian, Mahsa, et al.. (2018). Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond. Archivum Immunologiae et Therapiae Experimentalis. 67(2). 89–102. 38 indexed citations
18.
Sadeghi, Mohammad Amin, Mahsa Keshavarz‐Fathi, Vickie E. Baracos, et al.. (2018). Cancer cachexia: Diagnosis, assessment, and treatment. Critical Reviews in Oncology/Hematology. 127. 91–104. 148 indexed citations
19.
Rezahosseini, Omid, Sara Hanaei, Mehdi Hamadani, Mahsa Keshavarz‐Fathi, & Nima Rezaei. (2017). The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma. International Reviews of Immunology. 37(3). 165–173. 1 indexed citations
20.
Zamani, Mohammad, et al.. (2015). Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting: A systematic review. Journal of Critical Care. 32. 93–100. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Biao Zhang Breakdown of academic impact, for papers by Yuchao Chen Breakdown of academic impact, for papers by Ke Su Breakdown of academic impact, for papers by Hang Yu Breakdown of academic impact, for papers by Xi Huang Breakdown of academic impact, for papers by Kee‐Lung Chang Breakdown of academic impact, for papers by Sepideh Razi Breakdown of academic impact, for papers by Guoying Zhu Breakdown of academic impact, for papers by Haitian Lu Breakdown of academic impact, for papers by Shidong Wang
Rankless by CCL
2026